Neuronetics, Inc. Gains 36.84%
Mon, Jan 13, 2025 at 07:19 PM
Neuronetics, Inc. (STIM:NASDAQ) jumped higher at $2.34, representing a gain of 36.8%. On Mon, Jan 13, 2025, STIM:NASDAQ hit a New 2-Week High of $2.34. The stock appeared on our News Catalysts scanner on Mon, Jan 13, 2025 at 10:33 AM in the 'INVESTOR UPDATE' category. From Mon, Dec 30, 2024, the stock recorded 50.00% Up Days and 55.56% Green Days
About Neuronetics, Inc. (STIM:NASDAQ)
Neuronetics Inc is a commercial stage medical technology company. It is focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders.
Top 10 Gainers:
- Phio Pharmaceuticals Corp. (PHIO:NASDAQ), 290.53%
- Smart for Life Inc. (SMFL:NASDAQ), 260%
- Salarius Pharmaceuticals, Inc. (SLRX:NASDAQ), 135.26%
- Kairos Pharma Ltd. (KAPA:NYSEMKT), 119.59%
- Azitra Inc (AZTR:NYSEMKT), 59.72%
- Agape ATP Corporation (ATPC:NASDAQ), 56.35%
- Avinger, Inc. (AVGR:NASDAQ), 42.62%
- Neuronetics, Inc. (STIM:NASDAQ), 36.84%
- Sage Therapeutics, Inc. (SAGE:NASDAQ), 35.14%
- Intra-Cellular Therapies, Inc. (ITCI:NASDAQ), 34.07%